Form Type: 4

SEC EDGAR Link
Accession Number:0001179110-20-005297
Date:2020-04-28
Issuer: THERAVANCE BIOPHARMA, INC. (TBPH)
Original Submission Date:

Reporting Person:

GUNDERSON ROBERT V JR
GUNDERSON DETTMER STOUGH
1200 SEAPORT BLVD REDWOOD CITY, CA 94063

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
ORDINARY SHARES 2020-04-28 A 6,635 a $0.00 58,265 direct
ORDINARY SHARES 2020-04-28 0 $0.00 10,847 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
SHARE OPTION (RIGHT TO BUY) 30.14 2020-04-28 deemed execution date A 6,000 (a) 2030-04-27 ordinary shares 6,000 $30.14 6,000 direct
Footnotes
IDfootnote
f1 this option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date.
WhaleWisdom Logo

Elevate your investments